These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3915547)

  • 1. [Anticholinergic treatment in the therapy of primary enuresis. Effectiveness of oxybutynin chloride in a controlled clinical study of 58 patients].
    Marconi AM; Felici E; Roggia A; Torelli F
    Pediatr Med Chir; 1985; 7(4):573-6. PubMed ID: 3915547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxybutynin efficacy in the treatment of primary enuresis.
    Lovering JS; Tallett SE; McKendry JB
    Pediatrics; 1988 Jul; 82(1):104-6. PubMed ID: 3288951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nocturnal enuresis and daytime wetting: a multicentric trial with oxybutynin and desmopressin.
    Caione P; Arena F; Biraghi M; Cigna RM; Chendi D; Chiozza ML; De Lisa A; De Grazia E; Fano M; Formica P; Garofalo S; Gramenzi R; von Heland M; Lanza P; Lanza T; Maffei S; Manieri C; Merlini E; Miano L; Nappo S; Pagliarulo A; Paolini Paoletti F; Pau AC; Porru D; Artibani W
    Eur Urol; 1997; 31(4):459-63. PubMed ID: 9187908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of nocturnal enuresis in children with attention deficit hyperactivity disorder.
    Chertin B; Koulikov D; Abu-Arafeh W; Mor Y; Shenfeld OZ; Farkas A
    J Urol; 2007 Oct; 178(4 Pt 2):1744-7. PubMed ID: 17707010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Overdose of anticholinergic agents and confusional syndrome].
    Choulot JJ; Mensire A; Saint Martin J
    Ann Pediatr (Paris); 1989 Dec; 36(10):714. PubMed ID: 2624388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Primary enuresis -- combination therapy with oxybutynin plus desmopressin shows good results].
    Brudermanns B
    Aktuelle Urol; 2007 Mar; 38(2):86-8. PubMed ID: 17390271
    [No Abstract]   [Full Text] [Related]  

  • 7. Oxyphenon in the treatment of child enuresis.
    Hrbek J; Cupalová R; Tichá M
    Act Nerv Super (Praha); 1972; 14(2):84-5. PubMed ID: 4625134
    [No Abstract]   [Full Text] [Related]  

  • 8. Oxybutynin in bladder spasm, neurogenic bladder, and enuresis.
    Thompson IM; Lauvetz R
    Urology; 1976 Nov; 8(5):452-4. PubMed ID: 790746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Office management of pediatric primary nocturnal enuresis: a comparison of physician advised and parent chosen alternative treatment outcomes.
    Diaz Saldano D; Chaviano AH; Maizels M; Yerkes EB; Cheng EY; Losavio J; Porten SP; Sullivan C; Zebold KF; Hagerty J; Kaplan WE
    J Urol; 2007 Oct; 178(4 Pt 2):1758-61; discussion 1762. PubMed ID: 17707433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of urodynamic findings and response to oxybutynin in nocturnal enuresis.
    Persson-Jünemann C; Seemann O; Köhrmann KU; Jünemann KP; Alken P
    Eur Urol; 1993; 24(1):92-6. PubMed ID: 8365449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of oxybutynin, pseudoephedrine and indomethacin in the treatment of primary nocturnal enuresis.
    Varan B; Saatçi U; Ozen S; Bakkaloğlu A; Beşbaş N
    Turk J Pediatr; 1996; 38(2):155-9. PubMed ID: 8701478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refractory monosymptomatic nocturnal enuresis: a combined stepwise approach in childhood and follow-up into adolescence, with attention to the clinical value of normalizing bladder capacity.
    Vermandel A; de Wachter S; Wyndaele JJ
    BJU Int; 2005 Sep; 96(4):629-33. PubMed ID: 16104923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do holding exercises or antimuscarinics increase maximum voided volume in monosymptomatic nocturnal enuresis? A randomized controlled trial in children.
    Van Hoeck KJ; Bael A; Van Dessel E; Van Renthergem D; Bernaerts K; Vandermaelen V; Lax H; Hirche H; van Gool JD
    J Urol; 2007 Nov; 178(5):2132-6. PubMed ID: 17870123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should we switch over to tolterodine in every child with non-neurogenic daytime urinary incontinence in whom oxybutynin failed?
    Yucel S; Akkaya E; Guntekin E; Kukul E; Danisman A; Akman S; Baykara M
    Urology; 2005 Feb; 65(2):369-73. PubMed ID: 15708055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Older pharmacologic therapy for nocturnal enuresis.
    Rushton HG
    Clin Pediatr (Phila); 1993 Jul; Spec No():10-3. PubMed ID: 8039332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient bilateral blindness and posterior reversible encephalopathy syndrome: a rare complication of enuresis treatment.
    Branson JA; Dale RC
    J Paediatr Child Health; 2008 Jun; 44(6):380-2. PubMed ID: 18476934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of bladder capacity in antidiuretic and anticholinergic treatment for nocturnal enuresis.
    Radvanska E; Kovács L; Rittig S
    J Urol; 2006 Aug; 176(2):764-8; discussion 768-9. PubMed ID: 16813940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder.
    Goldenberg MM
    Clin Ther; 1999 Apr; 21(4):634-42. PubMed ID: 10363730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In which patients is the oxybutynin-desmopressin combination therapy indicated?].
    Martín-Crespo R; Luque R
    Cir Pediatr; 2003 Oct; 16(4):181-5. PubMed ID: 14677356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of enuresis: a controlled clinical trial of propantheline, propantheline-and-phenobarbitone and a placebo.
    Wallace IR; Forsythe WI
    Br J Clin Pract; 1969 May; 23(5):207-10. PubMed ID: 4889506
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.